141 related articles for article (PubMed ID: 36445289)
1. Soluble E-cadherin promotes invasiveness of neoplastic cells in salivary gland carcinoma ex pleomorphic adenoma.
Chen W; Ye S; Wang X; Qian J; Xia L; Tian Z
J Oral Pathol Med; 2023 Jan; 52(1):63-71. PubMed ID: 36445289
[TBL] [Abstract][Full Text] [Related]
2. Loss of expression of Plag1 in malignant transformation from pleomorphic adenoma to carcinoma ex pleomorphic adenoma.
de Brito BS; Giovanelli N; Egal ES; Sánchez-Romero C; Nascimento JS; Martins AS; Tincani ÁJ; Del Negro A; Gondak RO; Almeida OP; Kowalski LP; Altemani A; Mariano FV
Hum Pathol; 2016 Nov; 57():152-159. PubMed ID: 27473265
[TBL] [Abstract][Full Text] [Related]
3. [Carcinoma ex pleomorphic adenoma of major salivary glands--a clinicopathologic review].
Stodulski D; Rzepko R; Kowalska B; Stankiewicz C
Otolaryngol Pol; 2007; 61(5):687-93. PubMed ID: 18552001
[TBL] [Abstract][Full Text] [Related]
4. Expressions of androgen receptor and its co-regulators in carcinoma ex pleomorphic adenoma of salivary gland.
Nakajima Y; Kishimoto T; Nagai Y; Yamada M; Iida Y; Okamoto Y; Ishida Y; Nakatani Y; Ichinose M
Pathology; 2009; 41(7):634-9. PubMed ID: 19672785
[TBL] [Abstract][Full Text] [Related]
5. Cellular Proliferation Index between Carcinoma Ex-Pleomorphic Adenoma and Pleomorphic Adenoma.
Mariano FV; Costa AF; Gondak RO; Martins AS; Del Negro A; Tincani ÁJ; Altemani A; de Almeida OP; Kowalski LP
Braz Dent J; 2015; 26(4):416-21. PubMed ID: 26312983
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of carcinoma ex pleomorphic adenoma compared to de novo adenocarcinoma of major salivary glands.
Patel EJ; Oliver JR; Liu C; Tam M; Givi B
J Surg Oncol; 2021 Feb; 123(2):446-455. PubMed ID: 33145786
[TBL] [Abstract][Full Text] [Related]
7. Extracellular matrix remodelling and stiffening contributes to tumorigenesis of salivary carcinoma ex pleomorphic adenoma--A study based on patient-derived organoids.
Chen W; Gu T; Chen Q; Qu C; Zhang C; Hu Y; Xia R; Zhang Y; Wang M; Huang X; Li J; Shi C; Tian Z
Cell Biosci; 2023 Jul; 13(1):122. PubMed ID: 37393249
[TBL] [Abstract][Full Text] [Related]
8. Soluble-E-cadherin activates HER and IAP family members in HER2+ and TNBC human breast cancers.
Brouxhon SM; Kyrkanides S; Teng X; O'Banion MK; Clarke R; Byers S; Ma L
Mol Carcinog; 2014 Nov; 53(11):893-906. PubMed ID: 23776059
[TBL] [Abstract][Full Text] [Related]
9. HER-2/neu gene amplification in carcinoma ex pleomorphic adenoma in relation to progression and prognosis: a chromogenic in-situ hybridization study.
Hashimoto K; Yamamoto H; Shiratsuchi H; Nakashima T; Tamiya S; Nishiyama K; Higaki Y; Komune S; Tsuneyoshi M; Oda Y
Histopathology; 2012 May; 60(6B):E131-42. PubMed ID: 22486195
[TBL] [Abstract][Full Text] [Related]
10. Promoter hypermethylation may contribute to E‑cadherin repression in the human salivary carcinoma ex pleomorphic adenoma.
Xia L; Hu Y; Gu T; Wang L; Tian Z
Int J Oncol; 2018 Feb; 52(2):496-504. PubMed ID: 29207084
[TBL] [Abstract][Full Text] [Related]
11. Collagen type I may influence the expression of E-cadherin and beta-catenin in carcinoma ex-pleomorphic adenoma.
Araújo VC; Demasi AP; Furuse C; Altemani A; Alves VA; Freitas LL; Araújo NS
Appl Immunohistochem Mol Morphol; 2009 Jul; 17(4):312-8. PubMed ID: 19276972
[TBL] [Abstract][Full Text] [Related]
12. Carcinoma ex pleomorphic adenoma of the parotid gland.
Park KS; Kim JH; Lee DH; Lee JK; Lim SC
Am J Otolaryngol; 2022; 43(2):103389. PubMed ID: 35149345
[TBL] [Abstract][Full Text] [Related]
13. An immunohistochemical study of XIAP expression in pleomorphic adenoma and carcinoma ex pleomorphic adenoma.
Hoch BL; Wu M; Lewis M; Gan L; Burstein DE
J Oral Pathol Med; 2008 Nov; 37(10):634-8. PubMed ID: 18673415
[TBL] [Abstract][Full Text] [Related]
14. Increased SOX2 expression in salivary gland carcinoma ex pleomorphic adenoma progression: an association with adverse outcome.
Sedassari BT; Rodrigues MFSD; Conceição TS; Mariano FV; Alves VAF; Nunes FD; Altemani A; de Sousa SCOM
Virchows Arch; 2017 Dec; 471(6):775-784. PubMed ID: 28842747
[TBL] [Abstract][Full Text] [Related]
15. Carcinoma ex pleomorphic adenoma, with particular emphasis on early lesions.
Di Palma S
Head Neck Pathol; 2013 Jul; 7 Suppl 1(Suppl 1):S68-76. PubMed ID: 23821206
[TBL] [Abstract][Full Text] [Related]
16. Systematic review of prognostic factors in carcinoma ex pleomorphic adenoma.
Key S; Chia C; Hasan Z; Sundaresan P; Dwivedi RC; Riffat F
Oral Oncol; 2022 Oct; 133():106052. PubMed ID: 35921695
[TBL] [Abstract][Full Text] [Related]
17. Dual gain of HER2 and EGFR gene copy numbers impacts the prognosis of carcinoma ex pleomorphic adenoma.
Nishijima T; Yamamoto H; Nakano T; Nakashima T; Taguchi K; Masuda M; Motoshita J; Komune S; Oda Y
Hum Pathol; 2015 Nov; 46(11):1730-43. PubMed ID: 26345124
[TBL] [Abstract][Full Text] [Related]
18. Ectodomain-specific E-cadherin antibody suppresses skin SCC growth and reduces tumor grade: a multitargeted therapy modulating RTKs and the PTEN-p53-MDM2 axis.
Brouxhon SM; Kyrkanides S; Raja V; Silberfeld A; Teng X; Trochesset D; Cohen J; Ma L
Mol Cancer Ther; 2014 Jul; 13(7):1791-802. PubMed ID: 24748654
[TBL] [Abstract][Full Text] [Related]
19. Molecular Factors in Carcinoma Ex Pleomorphic Adenoma: Systematic Review and Meta-Analysis.
Key S; Chia C; Hasan Z; Sundaresan P; Riffat F; Dwivedi RC
Laryngoscope; 2024 Mar; 134(3):1042-1053. PubMed ID: 37610148
[TBL] [Abstract][Full Text] [Related]
20. Lymphatic vascular density and lymphangiogenesis during tumour progression of carcinoma ex pleomorphic adenoma.
Soares AB; Ponchio L; Juliano PB; de Araújo VC; Altemani A
J Clin Pathol; 2007 Sep; 60(9):995-1000. PubMed ID: 17079351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
